A. Egenvall, B. N. Bonnett, J. Häggström, S. Holst, B. Möller et al., Morbidity of insured Swedish cats during 1999-2006 by age, breed, sex, and diagnosis, J Feline Med Surg, vol.12, pp.948-59, 2010.

R. Graf, K. Grüntzig, G. Boo, M. Hässig, K. W. Axhausen et al., Swiss feline cancer registry 1965-2008: the influence of sex, breed and age on tumour types and tumour locations, J Comp Pathol, vol.154, pp.195-210, 2016.

M. Vascellari, E. Baioni, G. Ru, A. Carminato, and F. Mutinelli, Animal tumour registry of two provinces in northern Italy: incidence of spontaneous tumours in dogs and cats, BMC Vet Res, vol.5, p.39, 2009.

C. R. Dorn, D. O. Taylor, R. Schneider, H. H. Hibbard, and M. R. Klauber, Survey of animal neoplasms in Alameda and Contra Costa Counties, California. II. Cancer morbidity in dogs and cats from Alameda County, J Natl Cancer Inst, vol.40, pp.307-325, 1968.

H. M. Hayes, K. L. Milne, and C. P. Mandell, Epidemiological features of feline mammary carcinoma, Vet Rec, vol.108, pp.476-485, 1981.

C. J. Mcneill, K. U. Sorenmo, F. S. Shofer, L. Gibeon, A. C. Durham et al., Evaluation of adjuvant doxorubicin-based chemotherapy for the treatment of feline mammary carcinoma, J Vet Intern Med, vol.23, pp.123-132, 2009.

T. Ito, T. Kadosawa, M. Mochizuki, S. Matsunaga, R. Nishimura et al., Prognosis of malignant mammary tumor in 53 cats, J Vet Med Sci, vol.58, pp.723-729, 1996.

S. W. Mills, K. M. Musil, J. L. Davies, S. Hendrick, C. Duncan et al., Prognostic value of histologic grading for feline mammary carcinoma: a retrospective survival analysis, Vet Pathol, vol.52, pp.238-287, 2015.

F. Seixas, C. Palmeira, M. A. Pires, M. J. Bento, and C. Lopes, Grade is an independent prognostic factor for feline mammary carcinomas: a clinicopathological and survival analysis, Vet J, vol.187, pp.65-71, 2011.

M. Soares, J. Correia, M. C. Peleteiro, F. Ferreira, and . St, Gallen molecular subtypes in feline mammary carcinoma and paired metastases-disease progression and clinical implications from a 3-year follow-up study, Tumour Biol, vol.37, pp.4053-64, 2016.

R. Preziosi, G. Sarli, C. Benazzi, L. Mandrioli, and P. S. Marcato, Multiparametric survival analysis of histological stage and proliferative activity in feline mammary carcinomas, Res Vet Sci, vol.73, pp.53-60, 2002.

M. Goldschmidt, L. Peña, R. Rasotto, and V. Zappulli, Classification and grading of canine mammary tumors, Vet Pathol, vol.48, pp.117-148, 2011.

N. L. Barnes, J. L. Ooi, J. R. Yarnold, and N. J. Bundred, Ductal carcinoma in situ of the breast, BMJ, vol.344, p.797, 2012.

G. D. Leonard and S. M. Swain, Ductal carcinoma in situ, complexities and challenges, J Natl Cancer Inst, vol.96, pp.906-926, 2004.

C. I. Li, B. O. Anderson, J. R. Daling, and R. E. Moe, Changing incidence of lobular carcinoma in situ of the breast, Breast Cancer Res Treat, vol.75, pp.259-68, 2002.

B. A. Virnig, T. M. Tuttle, T. Shamliyan, and R. L. Kane, Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes, J Natl Cancer Inst, vol.102, pp.170-178, 2010.

F. Millanta, M. Calandrella, G. Bari, M. Niccolini, I. Vannozzi et al., Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues, Res Vet Sci, vol.79, pp.225-257, 2005.

F. Millanta, M. Calandrella, I. Vannozzi, and A. Poli, Steroid hormone receptors in normal, dysplastic and neoplastic feline mammary tissues and their prognostic significance, Vet Rec, vol.158, pp.821-825, 2006.

F. Millanta, G. Lazzeri, M. Mazzei, I. Vannozzi, and A. Poli, MIB-1 labeling index in feline dysplastic and neoplastic mammary lesions and its relationship with postsurgical prognosis, Vet Pathol, vol.39, pp.120-126, 2002.

R. Rasotto, D. Caliari, M. Castagnaro, R. Zanetti, and V. Zappulli, An immunohistochemical study of HER-2 expression in feline mammary tumours, J Comp Pathol, vol.144, pp.170-179, 2011.

G. Sarli, R. Preziosi, C. Benazzi, R. Bazzo, L. Mandrioli et al., Rate of apoptosis in feline mammary tumors is not predictive of postsurgical survival, J Vet Diagn Invest, vol.15, pp.115-137, 2003.

V. Zappulli, D. Caliari, R. Rasotto, S. Ferro, M. Castagnaro et al., Proposed classification of the feline "complex" mammary tumors as ductal and intraductal papillary mammary tumors, Vet Pathol, vol.50, pp.1070-1077, 2013.

G. P. Burrai, S. I. Mohammed, M. A. Miller, V. Marras, S. Pirino et al., Spontaneous feline mammary intraepithelial lesions as a model for human estrogen receptor-and progesterone receptor-negative breast lesions, BMC Cancer, vol.10, p.156, 2010.

L. Peña, A. Gama, M. H. Goldschmidt, J. Abadie, C. Benazzi et al., Canine mammary tumors: a review and consensus of standard guidelines on epithelial and myoepithelial phenotype markers, HER2, and hormone receptor assessment using immunohistochemistry, Vet Pathol, vol.51, pp.127-172, 2014.

R. Sánchez-céspedes, Y. Millán, S. Guil-luna, J. García-monterde, C. Reymundo et al., Myoepithelial cell layer integrity in canine mammary carcinoma, J Comp Pathol, vol.145, pp.25-30, 2011.

R. Sánchez-céspedes, A. Suárez-bonnet, Y. Millán, S. Guil-luna, C. Reymundo et al., Use of CD10 as a marker of canine mammary myoepithelial cells, Vet J, vol.195, pp.192-201, 2013.

M. Donker, S. Litière, G. Werutsky, J. P. Julien, I. S. Fentiman et al., Breast-conserving treatment with or without radiotherapy in ductal carcinoma In situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial, J Clin Oncol, vol.31, pp.4054-4063, 2013.

A. V. Barrio and K. J. Van-zee, Ductal carcinoma in situ of the breast: controversies and current management, Adv Surg, vol.53, pp.21-35, 2019.

S. A. Lari and H. M. Kuerer, Biological markers in DCIS and risk of breast recurrence: a systematic review, J Cancer, vol.2, pp.232-61, 2011.

M. G. Wallis, K. Clements, O. Kearins, G. Ball, J. Macartney et al., The effect of DCIS grade on rate, type and time to recurrence after 15 years of follow-up of screen-detected DCIS, Br J Cancer, vol.106, pp.1611-1618, 2012.

B. Erbas, E. Provenzano, J. Armes, and D. Gertig, The natural history of ductal carcinoma in situ of the breast: a review, Breast Cancer Res Treat, vol.97, pp.135-179, 2006.

E. G. Macewen, A. A. Hayes, H. J. Harvey, A. K. Patnaik, S. Mooney et al., Prognostic factors for feline mammary tumors, J Am Vet Med Assoc, vol.185, pp.201-205, 1984.

K. Weijer and A. A. Hart, Prognostic factors in feline mammary carcinoma, J Nat Cancer Inst, vol.70, pp.709-725, 1983.

V. Zappulli, R. Rasotto, D. Caliari, M. Mainenti, L. Peña et al., Prognostic evaluation of feline mammary carcinomas: a review of the literature, Vet Pathol, vol.52, pp.46-60, 2015.

E. Dagher, J. Abadie, D. Loussouarn, M. Campone, and F. Nguyen, Feline invasive mammary carcinomas: prognostic value of histological grading, Vet Pathol, vol.56, pp.660-70, 2019.
URL : https://hal.archives-ouvertes.fr/inserm-02167919

J. Cho, W. Han, J. W. Lee, E. Ko, S. Y. Kang et al., A scoring system to predict nonsentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a comparison with other scoring systems, Ann Surg Oncol, vol.15, pp.2278-86, 2008.

K. M. Chue, W. S. Yong, A. A. Thike, S. S. Ahmed, H. H. Li et al., Predicting the likelihood of additional lymph node metastasis in sentinel lymph node positive breast cancer: validation of the Memorial Sloan-Kettering Cancer Centre (MSKCC) nomogram, J Clin Pathol, vol.67, pp.112-121, 2014.

H. E. Kohrt, R. A. Olshen, H. R. Bermas, W. H. Goodson, D. J. Wood et al., New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients, BMC Cancer, vol.8, p.66, 2008.

R. Ponzone, F. Maggiorotto, L. Mariani, M. E. Jacomuzzi, A. Magistris et al., Comparison of two models for the prediction of nonsentinel node metastases in breast cancer, Am J Surg, vol.193, pp.686-92, 2007.

M. E. Straver, P. Meijnen, G. Van-tienhoven, C. J. Van-de-velde, R. E. Mansel et al., Sentinel node identification rate and nodal involvement in the EORTC 10981-22023 AMAROS trial, Ann Surg Oncol, vol.17, pp.1854-61, 2010.

R. F. Van-la-parra, P. G. Peer, W. K. De-roos, M. F. Ernst, J. H. De-wilt et al., A simple risk score to predict the presence of non-sentinel lymph node metastases in breast cancer patients with a positive sentinel node, World J Surg, vol.38, pp.1070-1076, 2014.

M. De-boer, C. H. Van-deurzen, J. A. Van-dijck, G. F. Borm, P. J. Van-diest et al., Micrometastases or isolated tumor cells and the outcome of breast cancer, N Engl J Med, vol.361, pp.653-63, 2009.

N. M. Hansen, B. Grube, X. Ye, R. R. Turner, R. J. Brenner et al., Impact of micrometastases in the sentinel node of patients with invasive breast cancer, J Clin Oncol, vol.27, pp.4679-84, 2009.

P. T. Truong, S. O. Jones, H. A. Kader, E. S. Wai, C. H. Speers et al., Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy, Int J Radiat Oncol Biol Phys, vol.73, pp.357-64, 2009.

B. C. Van-der-wal, R. M. Butzelaar, S. Van-der-meij, and M. A. Boermeester, Axillary lymph node ratio and total number of removed lymph nodes: predictors of survival in stage I and II breast cancer, Eur J Surg Oncol, vol.28, pp.481-490, 2002.

E. A. Mittendorf, A. A. Sahin, S. L. Tucker, F. Meric-bernstam, M. Yi et al., Lymphovascular invasion and lobular histology are associated with increased incidence of isolated tumor cells in sentinel lymph nodes from early-stage breast cancer patients, Ann Surg Oncol, vol.15, pp.3369-77, 2008.

S. Banerji, J. Ni, S. X. Wang, S. Clasper, J. Su et al., LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan, J Cell Biol, vol.144, pp.789-801, 1999.

I. Van-der-auwera, G. G. Van-den-eynden, C. G. Colpaert, S. J. Van-laere, P. Van-dam et al., Tumor lymphangiogenesis in inflammatory breast carcinoma: a histomorphometric study, Clin Cancer Res, vol.11, pp.7637-7679, 2005.

G. G. Van-den-eynden, I. Van-der-auwera, S. J. Van-laere, C. G. Colpaert, P. Van-dam et al., Distinguishing blood and lymph vessel invasion in breast cancer: a prospective immunohistochemical study, Br J Cancer, vol.94, pp.1643-1652, 2006.

F. J. Gujam, J. J. Going, J. Edwards, Z. M. Mohammed, and D. C. Mcmillan, The role of lymphatic and blood vessel invasion in predicting survival and methods of detection in patients with primary operable breast cancer, Crit Rev Oncol Hematol, vol.89, pp.231-272, 2014.

G. M. Freedman, T. Li, L. V. Polli, P. R. Anderson, R. J. Bleicher et al., Lymphatic space invasion is not an independent predictor of outcomes in early stage breast cancer treated by breast-conserving surgery and radiation, Breast J, vol.18, pp.415-424, 2012.

D. E. Rivadeneira, R. M. Simmons, P. J. Christos, K. Hanna, J. M. Daly et al., Predictive factors associated with axillary lymph node metastases in T1a and T1b breast carcinomas: analysis in more than 900 patients, J Am Coll Surg, vol.191, pp.1-8, 2000.

K. Tezuka, N. Onoda, T. Takashima, K. Takagaki, T. Ishikawa et al., Prognostic significance of lymphovascular invasion diagnosed by lymphatic endothelium immunostaining in breast cancer patients, Oncol Rep, vol.17, pp.997-1003, 2007.

P. T. Truong, C. M. Yong, F. Abnousi, J. Lee, H. A. Kader et al., Lymphovascular invasion is associated with reduced locoregional control and survival in women with node-negative breast cancer treated with mastectomy and systemic therapy, J Am Coll Surg, vol.200, pp.912-933, 2005.

E. A. Rakha, S. Martin, A. H. Lee, D. Morgan, P. D. Pharoah et al., The prognostic significance of lymphovascular invasion in invasive breast carcinoma, Cancer, vol.118, pp.3670-80, 2012.

P. J. Westenend, C. J. Meurs, and R. A. Damhuis, Tumour size and vascular invasion predict distant metastasis in stage I breast cancer. Grade distinguishes early and late metastasis, J Clin Pathol, vol.58, pp.196-201, 2005.

B. Ejlertsen, M. B. Jensen, F. Rank, B. B. Rasmussen, P. Christiansen et al., Population-based study of peritumoral lymphovascular invasion and outcome among patients with operable breast cancer, J Natl Cancer Inst, vol.101, pp.729-764, 2009.

M. Yi, E. A. Mittendorf, J. N. Cormier, T. A. Buchholz, K. Bilimoria et al., Novel staging system for predicting disease-specific survival in patients with breast cancer treated with surgery as the first intervention: time to modify the current American Joint Committee on Cancer staging system, J Clin Oncol, vol.29, pp.4654-61, 2011.

G. Sarli, F. Sassi, B. Brunetti, A. Rizzo, L. Diracca et al., Lymphatic vessels assessment in feline mammary tumours, BMC Cancer, vol.7, p.7, 2007.

S. Tanabe, T. Nakadai, H. Furuoka, T. Oomachi, Y. Kobayashi et al., Expression of mRNA of chemokine receptor CXCR4 in feline mammary adenocarcinoma, Vet Rec, vol.151, pp.729-762, 2002.

C. W. Elston and I. O. Ellis, Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up, Histopathology, vol.19, pp.403-413, 1991.

E. Dagher, J. Abadie, D. Loussouarn, D. Fanuel, M. Campone et al., Bcl-2 expression and prognostic significance in feline invasive mammary carcinomas: a retrospective observational study, BMC Vet Res, vol.15, p.25, 2019.
URL : https://hal.archives-ouvertes.fr/inserm-01991065

E. M. Ward, D. Santis, C. E. Lin, C. C. Kramer, J. L. Jemal et al., Cancer statistics: breast cancer in situ, CA Cancer J Clin, vol.65, pp.481-95, 2015.

S. Lee, S. K. Mohsin, S. Mao, S. G. Hilsenbeck, D. Medina et al., Hormones, receptors, and growth in hyperplastic enlarged lobular units: early potential precursors of breast cancer, Breast Cancer Res, vol.8, p.6, 2006.

T. W. Yen, K. K. Hunt, M. I. Ross, N. Q. Mirza, G. V. Babiera et al., Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ, J Am Coll Surg, vol.200, pp.516-542, 2005.

K. D. Yu, L. M. Wu, G. Y. Liu, J. Wu, G. H. Di et al., Different distribution of breast cancer subtypes in breast ductal carcinoma in situ (DCIS), DCIS with microinvasion, and DCIS with invasion component, Ann Surg Oncol, vol.18, pp.1342-1350, 2011.

M. Mori, K. Tsugawa, H. Yamauchi, H. Yagata, K. Suzuki et al., Pathological assessment of microinvasive carcinoma of the breast, Breast Cancer, vol.20, pp.331-336, 2013.

G. Karanikas, N. Koronakis, E. E. Lagoudianakis, D. Grosomanidis, G. Karavitis et al., The value of proliferation indexes in breast cancer, Eur J Gynaecol Oncol, vol.31, pp.181-185, 2010.

L. J. Solin, A. Fourquet, F. A. Vicini, M. Taylor, I. A. Olivotto et al., Long-term outcome after breast-conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast. Cancer, vol.103, pp.1137-1183, 2005.

K. U. Sorenmo, D. R. Woerley, and M. H. Goldschmidt, Withrow and MacEwen's Small Animal Clinical Oncology, pp.538-56, 2013.

S. Saadatmand, R. Bretveld, S. Siesling, and M. M. Tilanus-linthorst, Influence of tumour stage at breast cancer detection on survival in modern times: population based study in 173,797 patients, BMJ, vol.351, p.4901, 2015.

D. Martinez-ramos, J. Escrig-sos, A. Sanchez, M. Torrella-ramos, A. Salvador-sanchis et al., Disease-free survival and prognostic significance of metastatic lymph node ratio in T1-T2 N positive breast cancer patients. A population registry-based study in a European country, World J Surg, vol.33, pp.1659-64, 2009.

A. A. Hayes and S. Mooney, Feline mammary tumors, Vet Clin North Am Small Anim Pract, vol.15, pp.50054-50060, 1985.